STOCK TITAN

Zimmer Biomet (ZBH) CAO awarded 9,232 RSUs vesting over three years

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stellato Paul A reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. reported that VP, Controller and Chief Accounting Officer Paul A. Stellato received a grant of 9,232 Restricted Stock Units on May 1, 2026. Each unit represents a contingent right to receive one share of the company’s common stock.

The award vests annually over three years in equal one‑third installments, beginning on May 1, 2027. Following this grant, Stellato holds 9,232 Restricted Stock Units directly, reflecting a routine equity-based compensation award rather than an open-market stock purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Stellato Paul A
Role VP, Controller, CAO
Type Security Shares Price Value
Grant/Award Restricted Stock Units 9,232 $0.00 --
Holdings After Transaction: Restricted Stock Units — 9,232 shares (Direct, null)
Footnotes (1)
  1. Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock. Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.
RSUs granted 9,232 units Equity award to Paul A. Stellato on May 1, 2026
RSUs outstanding after grant 9,232 units Total Restricted Stock Units held directly after transaction
Vesting schedule 1/3 annually over 3 years Vesting begins on May 1, 2027
RSU-to-share ratio 1 unit : 1 share Each RSU represents right to one common share
Restricted Stock Units financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of the Company's common stock"
vests annually over three years financial
"Vests annually over three years in increments of one-third each year"
increment of one-third each year financial
"in increments of one-third each year, commencing on May 1, 2027"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stellato Paul A

(Last)(First)(Middle)
345 E. MAIN STREET

(Street)
WARSAW INDIANA 46580

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP, Controller, CAO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/01/2026A9,232 (2) (2)Common Stock9,232$09,232D
Explanation of Responses:
1. Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.
2. Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Paul A. Stellato (power of attorney previously filed)05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ZIMMER BIOMET (ZBH) report for Paul A. Stellato?

ZIMMER BIOMET reported that Paul A. Stellato received a grant of 9,232 Restricted Stock Units. These units are a form of equity compensation and each represents a contingent right to receive one share of common stock, subject to future vesting conditions over a multi‑year period.

When do Paul A. Stellato’s new ZIMMER BIOMET (ZBH) RSUs vest?

The 9,232 Restricted Stock Units vest over three years in equal one‑third annual installments. Vesting begins on May 1, 2027, meaning a portion becomes deliverable each year, provided the vesting conditions are satisfied during the three‑year period.

How many ZIMMER BIOMET (ZBH) RSUs does Paul A. Stellato hold after this Form 4?

After the reported transaction, Paul A. Stellato holds 9,232 Restricted Stock Units directly. This matches the number of units granted in the award and reflects his equity-based compensation position disclosed in this filing, without indicating any open-market stock purchases or sales.

What does each Restricted Stock Unit in ZIMMER BIOMET’s grant to Stellato represent?

Each Restricted Stock Unit represents a contingent right to receive one share of ZIMMER BIOMET common stock. Delivery of shares depends on the RSUs vesting under the award’s schedule, which requires continued satisfaction of vesting conditions over the specified three‑year period.

Is the ZIMMER BIOMET (ZBH) Form 4 for Paul A. Stellato a stock sale or purchase?

The Form 4 reflects a grant of 9,232 Restricted Stock Units as compensation, not an open‑market stock sale or purchase. It is classified as an acquisition through a grant or award, with no reported market trading activity in the company’s common shares.